PhD Alenka Grošel

PhD Alenka Grošel
no.: 21329 source: ARIS

researcher – not employed in research organisation
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Serbo-Croatian (Roman)
  • Reading: Fluent
  • Writing: Functional
  • Speaking: Fluent
  • German
  • Reading: Functional
  • Writing: Functional
  • Speaking: Basic
  • Spanish
  • Reading: Basic
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
2.06.07  Engineering sciences and technologies  Systems and cybernetics  Biomedical technics 
Keywords
tumor biology, electroporation, electrogene therapy, electrochemoti therapy
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
0
A''
0
A'
0
A1/2
0
CI10
78
CImax
21
h10
5
A1
0
A3
0
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 13  234  153  11.77 
Scopus 14  320  212  15.14 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.   Microbiology  SI University of Ljubljana, Biotechnical Faculty 1999 
Master's degree  M. Sc.   Biochemistry and Molecular biology  SI University of Ljubljana, Faculty of Medicine 2003 
Doctoral degree  Ph. D.   Medical sciences  SI University of Ljubljana, Faculty of Medicine 2005 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,640 
2. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,319 
3. J3-2529  Role of endothelium in tumor response to radiotherapy   9/1/2020 - 8/31/2023  PhD Boštjan Markelc   3,723 
4. J3-6796  Translacijska onkologija: razvoj in validacija imunsko genske terapije z interleukinom-12 v kombinaciji s kirurgijo pri oralnih in kožnih tumorjih psov (Slovene)   7/1/2014 - 6/30/2017  PhD Maja Čemažar   5,190 
5. J3-4211  Antiangiogena genska terapija raka: tarčno zdravljenje z uporabo elektroporacije in magnetnih nanodelcev kot dostavnih sistemov (Slovene)   7/1/2011 - 6/30/2014  PhD Gregor Serša   6,891 
6. J3-2277  Kombinacija elektrogenske imunske terapije z interlevkinom-12 in obsevanjem za zdravljenje eksperimentalnih tumorjev (Slovene)   5/1/2009 - 4/30/2012  PhD Maja Čemažar   2,984 
7. J3-7044  Treatment of malignant tumours with electrogene therapy   9/1/2005 - 8/31/2008  PhD Maja Čemažar   3,521 
8. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   7/1/2002 - 6/30/2005  PhD Maja Čemažar   5,082 
9. J3-3489  New biomedical applications of electroporation   7/1/2001 - 6/30/2004  PhD Gregor Serša   4,273 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2009 - 12/31/2014 PhD Gregor Serša   4,296 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   7/1/2004 - 12/31/2008 PhD Gregor Serša   3,282 
Confirmation required
Views history
Favourite